Do Patients with a Left Ventricular Ejection Fraction between 30% and 35% Benefit from a Primary Prevention Implantable Cardioverter Defibrillator?
Document Type
Article
Publication Date
2014
Recommended Citation
Al-Khatib, S. M., Han, J. Y., Edwards, R., Bardy, G. H., Bigger, J. T., Buxton, A. E., . . . Kadish, A. H. (2014). Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? International Journal of Cardiology, 172(1), 253-254.
Publisher's Statement
The original material can be found here: doi:10.1016/j.ijcard.2013.12.278
Comments
Please see the work itself for the complete list of authors.